Biocare Medical would like to thank you for making the 105th Annual United States and Canadian Academy of Pathology in Seattle, WA a great success! Many attendees took advantage of a great opportunity to learn more about our innovative IHC, ISH and FISH products from antibodies to instrumentation.

Biocare was proud to be involved in three poster presentations, highlighting some great uses for Multiplex IHC and new diagnosis techniques. To learn more about a pHH3 rabbit monoclonal in melanoma, Synkii in multiple myeloma and multiplex strategies in colon adenocarcinoma please visit to download the posters.

We hope that you had a chance to join us for our exhibitor seminar, where we presented on two exciting topics. In prostate cancer, ERG oncoprotein expression is associated with favorable outcomes. We saw data showing a significantly lower proportion of ERG positive foci were observed in the index tumors of African American and Caucasian American patients within an equal-access military healthcare system. In addition, we learned about 2 assays SynKii (Syndecan 1 [CD138] / Ki67) and MumKii (MUM1 / Ki67) for myeloma-cell-specific proliferation. The data suggests that use of these assays can be used in lieu of cytogenetics for risk stratification.

Thank you for making the show such a great success.

We hope to see everybody next year at USCAP 2017 in San Antonio, TX!